Lataa...
Using the Immunophenotype to Predict Response to Biologic Drugs in Rheumatoid Arthritis
Tumour necrosis factor (TNF)-α is a key mediator of inflammation in rheumatoid arthritis, and its discovery led to the development of highly successful anti-TNF therapy. Subsequently, other biologic drugs targeting immune pathways, namely interleukin-6 blockade, B cell depletion, and T cell co-stimu...
Tallennettuna:
| Julkaisussa: | J Pers Med |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6963853/ https://ncbi.nlm.nih.gov/pubmed/31581724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm9040046 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|